Use of AMSTAR-2 in the methodological assessment of systematic reviews: protocol for a methodological study
暂无分享,去创建一个
Nan Yang | Kehu Yang | Cuncun Lu | Tingting Lu | Long Ge | Peijing Yan | Kehu Yang | Peijing Yan | Cuncun Lu | L. Ge | N. Yang | Ting-ting Lu
[1] D. Pieper,et al. How is AMSTAR applied by authors – a call for better reporting , 2018, BMC Medical Research Methodology.
[2] Sally Hopewell,et al. Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study , 2013, BMJ Open.
[3] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[4] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.
[5] P. Dahm,et al. A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer , 2018, BMJ Open.
[6] Cuncun Lu. Comment on: "Ginger for health care - An overview of systematic reviews". , 2019, Complementary therapies in medicine.
[7] F. Song,et al. Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study. , 2018, Journal of clinical epidemiology.
[8] J. McKenzie,et al. Toward a comprehensive evidence map of overview of systematic review methods: paper 1—purpose, eligibility, search and data extraction , 2017, Systematic Reviews.
[9] Xiaobin Zhou,et al. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer’s disease before and after PRISMA introduction , 2018, BMC Medical Research Methodology.
[10] Rachel Churchill,et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed , 2016, Journal of clinical epidemiology.
[11] Kehu Yang,et al. Top-100 Most Cited Publications Concerning Network Pharmacology: A Bibliometric Analysis , 2019, Evidence-based complementary and alternative medicine : eCAM.
[12] Kehu Yang,et al. Trace and evaluation systems for health services quality in rural and remote areas: a systematic review , 2018, Journal of Public Health.
[13] A. Cipriani,et al. Meta-Review: Network Meta-Analyses in Child and Adolescent Psychiatry. , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.
[14] D. Pieper,et al. Can AMSTAR also be applied to systematic reviews of non-randomized studies? , 2014, BMC Research Notes.
[15] Peter C Gøtzsche,et al. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review , 2006, BMJ : British Medical Journal.
[16] G. Guyatt,et al. Going from evidence to recommendations , 2008, BMJ : British Medical Journal.
[17] Kehu Yang,et al. The methodological quality of robotic surgical meta-analyses needed to be improved: a cross-sectional study. , 2019, Journal of clinical epidemiology.
[18] C. Faggion,et al. Systematic reviews in orthodontics: Impact of the PRISMA for Abstracts checklist on completeness of reporting. , 2019, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.
[19] David Moher,et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement , 2018 .
[20] David Moher,et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.
[21] Becky Skidmore,et al. Systematic reviews of clinical practice guidelines: a methodological guide. , 2019, Journal of clinical epidemiology.
[22] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2015, BMJ : British Medical Journal.
[23] Ya-nan Luo,et al. Methodological and reporting quality evaluation of systematic reviews on acupuncture in women with polycystic ovarian syndrome: A systematic review. , 2018, Complementary therapies in clinical practice.
[24] Kristian Thorlund,et al. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.
[25] D. Pieper,et al. Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic reviews including both randomized and nonrandomized studies. , 2019, Journal of clinical epidemiology.
[26] Jinhui Tian,et al. Methodology and reporting quality of Cochrane network meta-analyses provides the room to improve the network geometry and inconsistency. , 2019, Journal of clinical epidemiology.
[27] Kehu Yang,et al. Ginger for health care: An overview of systematic reviews. , 2019, Complementary therapies in medicine.
[28] K. Dickersin,et al. Evaluation of Systematic Reviews of Interventions for Retina and Vitreous Conditions. , 2019, JAMA ophthalmology.
[29] P. Tugwell,et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.
[30] M. Oremus,et al. PRISMA and AMSTAR show systematic reviews on health literacy and cancer screening are of good quality. , 2018, Journal of clinical epidemiology.
[31] D. Pieper,et al. A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool. , 2019, Journal of clinical epidemiology.
[32] J. Ioannidis. Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews , 2017, British Journal of Sports Medicine.
[33] G. Guyatt,et al. How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature. , 2014, JAMA.